Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Arcturus, Astrazeneca, Biocure Technology, Capricor, Celltrion, Hutchison China Meditech, Pharos Vaccine, Tracon.